New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2013
12:19 EDTLUFK, GE, FTK, WFT, BCRX, OMPI, VRX, JNJOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as investors await the start of the latest earnings season, which kicks off unofficially after today's close with Alcoa's (AA) report. The averages all fell into negative ground soon after the open and found a level, from which they have been range-bound ever since. With a very quiet economic calendar today and generally depressed expectations for the earnings seasons, the lackluster trading may extend from here until the close... ECONOMIC EVENTS: In the U.S., no major economic data was reported... COMPANY NEWS: General Electric (GE) agreed to acquire Lufkin (LUFK), which supplies products, technology and services to the oil and gas industry, for $3.3B, or $88.50 per share in cash. Lufkin soared over 37% to trade within 50c of the agreed upon per share price at midday, while some of its peers rose as well, including Flotek (FTK) and Weatherford (WFT), which both advanced over 3%. GE shares, meanwhile, slid 0.4%... MAJOR MOVERS: Among the notable gainers was BioCryst (BCRX), which rose 22% amid reports of new bird flu infections in China. BioCryst is developing peramivir, an investigational anti-viral agent to treat influenza. Among the noteworthy losers was Obagi Medical (OMPI), which fell 6% after Merz Pharma withdrew its offer to acquire Obagi in the face of a $24 per share competing offer from Valeant Pharmaceuticals (VRX). Also lower were shares of Johnson & Johnson (JNJ), which slid nearly 2% after JPMorgan lowered it rating on the stock to Neutral from Overweight... INDICES: Near noon, the Dow was down 51.84, or 0.36%, to 14,513.41; the Nasdaq was down 3.11, or 0.10%, to 3,200.75; and the S&P 500 was down 1.63, or 0.10%, to 1,551.65.
News For LUFK;GE;FTK;WFT;BCRX;OMPI;VRX;JNJ From The Last 14 Days
Check below for free stories on LUFK;GE;FTK;WFT;BCRX;OMPI;VRX;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 14, 2014
09:06 EDTGEEmirates signs $13B GE9X services agreement
Subscribe for More Information
08:30 EDTJNJJohnson & Johnson should be bought on any weakness, says RBC Capital
Subscribe for More Information
08:13 EDTVRXAllergan reiterates belief that Valeant model unsustainable in new presentation
Subscribe for More Information
08:02 EDTVRXValeant submits HSR filing for proposed acquisition of Allergan
Subscribe for More Information
07:43 EDTGEGE far ahead of Caterpillar in race for cleaner diesel train, WSJ says
Caterpillar (CAT) has fallen far behind in the race to offer a locomotive that meets stricter emission standards taking effect next year, with its Electro-Motive Diesel unit stating that its freight trains probably won't be available until 2017, while General Electric (GE) is already testing trains that comply with the new rules, reported The Wall Street Journal. Reference Link
07:30 EDTWFTWeatherford to sell Rosneft Russia and Venezuelan operations for $500M
Subscribe for More Information
July 13, 2014
11:40 EDTGEAmerican selects CFM engine to power A320 in order valued $2.6B
American Airlines (AAL) has selected CFM International’s advanced LEAP-1A engine to power its new fleet of 100 Airbus (EADSY) A320neo family aircraft. CFM values the engine order at $2.6B U.S. at list price. The aircraft order was originally announced in July 2011 and American will begin taking delivery in 2017. American also has orders for LEAP-1B engines to power 100 Boeing 737 MAX aircraft, which are also scheduled to be delivered beginning in 2017. American has been a CFM customer since 1996 and the airline’s fleet includes 375 Airbus A320 Family and Boeing 737 aircraft powered by CFM56 engines. CFM International is a 50/50 joint company between Safran and General Electric (GE).
July 12, 2014
18:08 EDTGEeasyJet said to choose GE-Safran engine for Airbus jets, WSJ says
easyJet (ESYJY) is set to order engines from a partnership of General Electric (GE) and France's Safran to power 100 Airbus Group (EADSY) NV A320neo jets, says the Wall Street Journal. According to the WSJ report United Technologies (UTX) unit Pratt & Whitney was also aggressively competing for the order. Reference Link
July 11, 2014
16:48 EDTVRXAllergan comments on Pershing Square’s definitive proxy solicitation
Allergan (AGN) provided the following comment in response to the definitive proxy solicitation filed by Pershing Square Capital Management in connection with Pershing Square’s request to call a Special Meeting of Stockholders. At the Special Meeting, if called, Allergan stockholders would be asked to remove a majority of the company’s existing directors in connection with Valeant Pharmaceuticals' (VRX) unsolicited exchange offer to acquire all outstanding common shares of Allergan for 0.83 shares of Valeant common stock and $72.00 in cash, or subject to proration, an amount of cash or a number of Valeant common shares with the implied value set forth in the exchange offer. Under the current Board’s leadership, which includes individuals with significantly more industry experience than Pershing Square’s recommended nominees, Allergan continues to execute on its plan to drive near- and long-term organic growth, enhance its growth prospects and continue generating significant value for all of Allergan’s stockholders. We believe Pershing Square’s attempt to replace a majority of the Allergan Board is a further effort to support Valeant in its bid to acquire Allergan at a grossly inadequate price that substantially undervalues the company and creates significant risks and uncertainties for Allergan stockholders. Valeant has repeatedly failed to address the serious concerns raised by Allergan and important members of the investment community about Valeant’s anemic organic growth driven by unsustainable price increases, among other fundamental business model issues. Allergan has a track record of consistently acting in the best interests of its stockholders and the Board remains confident in the company’s ability to create significantly more value than Valeant’s proposal.
08:05 EDTGEGE Capital increases credit facility for OraMetrix
GE Capital’s Healthcare Financial Services business announced that it is the sole lender on a $10M senior secured term loan for OraMetrix. This transaction refinances the company’s previous $7.5M multi-draw senior secured term loan facility and provides it with an additional $2.5M. The funds will be used for working capital and growth initiatives.
08:03 EDTGEGE Capital provides MerchSource with $130M credit facility
GE Capital announced it is providing MerchSource with a $130M senior credit facility providing working capital for the company’s operations in the U.S. and Hong Kong.
07:45 EDTGEWith Alstom agreement settled, attention on GE turns to earnings, Reuters says
Subscribe for More Information
07:36 EDTJNJJohnson & Johnson Q2 EPS likely to exceed expectations, says Bernstein
Subscribe for More Information
July 10, 2014
09:31 EDTVRXNestle acquires rights to aesthetic dermatology products in the U.S. and Canada
Subscribe for More Information
09:31 EDTVRXValeant completes filler, toxin asset sale to Galderma
Subscribe for More Information
07:29 EDTGEGeneral Electric volatility elevated into Q2 and revenue outlook
Subscribe for More Information
July 9, 2014
18:31 EDTVRXShareholders urge Allergan to make large acquisition, FT reports
Subscribe for More Information
18:21 EDTVRXAllergan CEO seeks sizeable acquisitions, WSJ reports
Subscribe for More Information
07:06 EDTGEUniversal Stainless & Alloy achieves S-400, S-1000 approvals from GE Aviation
Subscribe for More Information
06:19 EDTVRXAllergan plans broad restructuring plan, Bloomberg says
Allergan (AGN), the pharmaceutical maker that is being chased by Valeant (VRX) and Bill Ackman’s hedge fund, will shelve unpromising pipeline medicines and revamp management incentives, according to Bloomberg, citing two people with knowledge of the matter. The sources said that the restructuring plan, which is set to be explained during Allergan's upcoming earnings announcement, will also detail companywide cost reductions including some legacy expenses. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use